Compound library / Tanning / Photoprotection
Melanocortin agonist; the FDA-approved version (Scenesse, afamelanotide) treats a rare light sensitivity disorder (EPP), but it's widely sourced grey-market for general tanning, distinct from Melanotan II.
| Category | Tanning / Photoprotection |
|---|---|
| Typical route | Subcutaneous |
| Half-life | ~bound implant releases over ~2 months (Scenesse) or hours (research vials) |
| Common dose range | Scenesse: 16mg implant every 2 months (clinical). Grey-market vials: highly variable, unregulated. |
| Typical cycle length | Varies by formulation |
BioHack Track models Melanotan I (Afamelanotide) at a half-life of 1 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Grey-market vials reconstitute with bacteriostatic water; the approved implant requires clinical administration.
Refrigerate reconstituted research vials.
Only the implant formulation for EPP is FDA-approved and clinically administered; self-sourced injectable versions are unregulated and carry the same pigmentation/mole-monitoring concerns as Melanotan II.
Track Melanotan I (Afamelanotide) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Melanotan I (Afamelanotide) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.